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A second trimester fetal demise followed inﬂ  uenza-like 
illness in early pregnancy. Inﬂ  uenza A virus (H1N1) was iden-
tiﬁ  ed in maternal and fetal tissue, conﬁ  rming transplacental 
passage. These ﬁ  ndings suggested a causal relationship 
between early exposure and fetal demise. Management 
of future inﬂ  uenza outbreaks should include evaluation of 
products of conception associated with fetal loss.
I
ncreased maternal illness and death appeared in early 
reports of inﬂ  uenza A pandemic (H1N1) 2009. Three 
pregnancy-related complications associated with pandemic 
(H1N1) 2009 were reported in May 2009: 1 postpartum 
maternal death, 1 preterm birth, and 1 early second trimes-
ter (weeks 14–20) loss (1). In April 2010, a summary of 
pandemic (H1N1) 2009 among 788 pregnant women dem-
onstrated a disproportionately high risk for death; the rate 
of spontaneous miscarriage was 1.4%, but details were not 
provided (2). Correlating inﬂ  uenza exposure to pregnancy 
loss is not straightforward because ﬁ  rst trimester miscar-
riage is common, second trimester loss before 24 weeks is 
not well studied (3), and viral identiﬁ  cation in products of 
conception has rarely been attempted. We report a second 
trimester fetal demise that occurred after exposure to sea-
sonal inﬂ  uenza A virus (H1N1) early in pregnancy.
The Case
In 2008, a 30-year-old primigravida physician experi-
enced intrauterine fetal demise (IUFD) at 20 weeks’ gesta-
tion, as established by last menstrual period and conﬁ  rmed 
by ultrasound at 8 weeks. The patient spent most of her 
pregnancy providing direct patient care. In October 2007, 
during gestational weeks 2–6, she was exposed to at least 2 
patients with presumed inﬂ  uenza. She reported symptoms 
of fever, myalgia, headache, and cough during gestational 
week 4. She had no testing for inﬂ  uenza, did not receive an-
tiviral therapy, and took acetaminophen; her symptoms re-
solved. She received the killed seasonal inﬂ  uenza vaccine 
at gestational week 6. An ultrasound at 18 weeks demon-
strated early growth restriction and oligohydramnios with 
normal appearing fetal kidneys and head. IUFD was noted 
at 20 weeks.
The patient had an unremarkable medical history, did 
not smoke, and was normotensive throughout pregnancy. 
Antibodies to cytomegalovirus and toxoplasmosis were not 
detected.
The immature placenta showed no visible abnormali-
ties. Microscopically, histiocytes were abundant in the ma-
ternal space (chronic intervillositis) and were noted within 
the fetal chorionic villi (Hofbauer cells; Figure 1, panel 
A). Histologic analysis of fetal autopsy specimens showed 
scattered luminal histiocytes of the lung and gut. No other 
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Figure 1. Tissue sample from 30-year-old primigravida patient 
exposed to seasonal inﬂ  uenza (H1N1).  A) Intervillous (maternal) 
spaces with clusters/sheets of histiocytes (chronic intervillositis) 
and  ﬁ   brotic fetal chorionic villi with Hofbauer cells–histiocytic 
inﬂ  ammation (hematoxylin and eosin stain, original magniﬁ  cation 
×200). B) Dual-stained immunoﬂ   uorescent assay showing 
antibodies to inﬂ   uenza A virus (H1N1) (tetramethylrhodamine 
isothiocyanate, red) and cytokeratin (ﬂ  uorescein  isothiocyanate, 
green) in intravillous (fetal) and intervillous (maternal) space.
Author afﬁ  liation: University of Michigan Health System, Ann Arbor, 
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DOI: 10.3201/eid1701.091895inﬂ  ammatory changes or viral inclusions were identiﬁ  ed in 
the placenta or fetal organs.
Chronic intervillositis was evident in the placental his-
tology and has been previously described with nonspeciﬁ  c 
changes in miscarriage and recurrent pregnancy loss (4). 
Formalin-ﬁ  xed placental tissue was imaged with electron 
microscopy. Histiocytes identiﬁ  ed from the maternal inter-
villous space and fetal chorionic villi demonstrated charac-
teristics of viral production (Figure 2). Several well-formed 
viral capsids were noted within the cytoplasm, each con-
taining regularly spaced projections along the surface of the 
virion corresponding to the hemagglutinin and neuramini-
dase spikes.
PCR for M1 capsid protein conﬁ  rmed inﬂ  uenza A. Im-
munohistochemical testing was performed on tissue from 
the placenta and on a sampling of fetal organs by using 
inﬂ  uenza A virus (H1N1)–speciﬁ  c antibody. In the placen-
ta, stippled immunoﬂ  uorescence (Figure 1, panel B) was 
noted in the histiocytes of the intervillous space (maternal) 
and fetal intravillous histiocytes. In the fetal organs, immu-
noﬂ  uorescence for subtype H1N1 was notable in the sur-
face epithelial cells and scattered luminal histiocytes of the 
fetal respiratory and gastrointestinal tracts. No immunoﬂ  u-
orescence was noted within the fetal organs, which implied 
transamnionic passage of virus (amnionic ﬂ  uid infection). 
The fetus was XY karyotype. Y-speciﬁ  c immunoﬂ  uores-
cent stain with histiocyte counterstaining was performed. 
Because only the intravillous (fetal) histiocytes stained 
positively, maternal and fetal inﬂ  ammatory responses were 
conﬁ  rmed.
Conclusions
Harris reported higher rates of miscarriage after expo-
sure and infection in the earliest months of pregnancy in the 
Spanish inﬂ  uenza outbreak of 1918 (subtype H1N1) (5). 
Hardy et al. reported a similar observation following the 
Asian inﬂ  uenza outbreak of 1957–58 (6), as did investiga-
tors in the United Kingdom during the 1985–86 inﬂ  uenza 
season (7).
Several case reports document transplacental trans-
fer of inﬂ  uenza virus. Yawn et al. documented inﬂ  uenza 
A transplacental transfer from the mother to amniotic ﬂ  uid 
and fetal heart (8). Mel’nikova et al. summarized placen-
tal ﬁ  ndings associated with inﬂ  uenza infections in publi-
cations from 1987 and 1994, describing perivillous and 
villous inﬂ  ammation with concurrent amniotic ﬂ  uid im-
munoﬂ  uorescence for inﬂ  uenza virus (9). In another study 
(10), researchers from Beijing, People’s Republic of China, 
reported autopsy ﬁ  ndings for 2 patients (1 of whom was 4 
months pregnant) who died of avian inﬂ  uenza A (H5N1). 
Viral antigens were present in the maternal pulmonary 
system, and virus was detected in placental Hofbauer cells 
(histiocytes), cytotrophoblast, fetal lung, circulating mono-
nuclear cells, and liver macrophages (10). Their documen-
tation of tropism of the inﬂ  uenza virus to placental tissue 
is similar to the histopathologic features in our report. Our 
unexpected discovery of viral production in placental, ma-
ternal, and fetal histiocytes is another example of transpla-
cental passage of inﬂ  uenza.
Miscarriage or completion of pregnancy may follow 
nonfatal maternal inﬂ  uenza infection. Adverse fetal out-
comes have reportedly included congenital malformation 
and schizophrenia, but factors that determine these effects 
remain unclear (11,12). Fetal consequences of inﬂ  uenza 
exposure may be an effect of systemic inﬂ  ammatory re-
sponse to the infection, which could represent direct action 
of the virus on the placenta, the maternal–fetal interface, or 
the fetus. Uchide et al. reported the inﬂ  ammatory response 
of decidual and fetal tissue in the presence of inﬂ  uenza vi-
rus infection and demonstrated expression of mRNA for 
a set of proinﬂ  ammatory cytokines such as interleukin-6, 
tumor necrosis factor-α, and granulocyte–macrophage col-
ony-stimulating factor, secreted in substantial amounts in 
response to exposure to inﬂ  uenza virus in vitro (13). As our 
case suggests, a complex interaction of maternal and fetal 
responses at the interface is a more likely explanation.
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Figure 2. Tissue sample from 30-year-old primigravida patient 
exposed to seasonal inﬂ   uenza (H1N1).  Electron microscopy 
(original magniﬁ  cation ×70,000) of maternal intervillous space and 
fetal chorionic villi, showing intranuclear viral transcription aligning 
along the nuclear envelope–electron hypodensities (asterisks), 
and intracytoplasmic viral production in varying stages shown 
by numerous electron densities (V and ^). Scale bar = 500 nm. 
Inset: enlarged image of mature virion with capsular projections. 
Ultrastructural features are characteristic of inﬂ  uenza  viruses. 
Scale bar = 100 nm.Inﬂ  uenza in Early Pregnancy and Fetal Demise
A total of 15%–20% of pregnancies end in spontane-
ous miscarriage, most before gestational week 12 (3). Ap-
proximately 50% of miscarriages are associated with chro-
mosomal defects, which leaves many other miscarriages 
unexplained (14). Redline et al. examined ﬁ  rst trimester 
miscarriages not associated with chromosomal abnormal-
ity, observing histologic changes of chronic intervillositis 
and increased perivillous ﬁ  brin (15). The mechanism of 
loss was thought to be related to a maternal inﬂ  ammatory 
response to infectious antigen or an autoimmune phenom-
enon. Whether these ﬁ  ndings can be extrapolated to second 
trimester losses is unknown. Second trimester miscarriages 
account for only 1%–2% of all pregnancy losses (3). Histo-
pathologic features of these early second trimester miscar-
riages are not well studied, and descriptions are usually in-
cluded in reports of fetal losses during 14–27 weeks, which 
include IUFD (>20 weeks) and miscarriage. Consequently, 
a direct causal relationship between inﬂ  uenza A and fetal 
demise has not been well established.
In our report, a retrospective investigation of the pa-
tient’s products of conception with ultrastructural, immu-
nohistochemical, and molecular methods that identiﬁ  ed 
subtype H1N1 implies an exposure during her ﬁ  rst trimes-
ter. Type-speciﬁ  c serologic analysis was not possible be-
cause she received inﬂ  uenza vaccine several weeks after 
presumed exposure. The maternal and fetal inﬂ  ammatory 
responses (chronic intervillositis) after placental infection 
may have reduced villous surface area for oxygen and 
nutrient transport, resulting in growth restriction and ulti-
mately second trimester loss.
Investigation of the effects of inﬂ  uenza in early preg-
nancy is needed to evaluate potential pathophysiological 
relationships between maternal exposure, infection, and fe-
tal loss or adverse outcome. During the 2009–10 inﬂ  uenza 
pandemic, the Centers for Disease Control and Prevention 
(Atlanta, GA, USA) collected information from popula-
tions exposed to and infected with pandemic (H1N1) 2009 
virus. Products of conception were not included among the 
samples cataloged. We recommend that future inﬂ  uenza 
outbreak evaluations of women exposed to inﬂ  uenza with 
ﬁ  rst or early second trimester pregnancy loss include col-
lections of placental and fetal tissue samples.
Initial report data were presented at Frontiers of Pathology, 
September 2008, University of Michigan Department of Pathol-
ogy, Ann Arbor, Michigan, USA.
Internal funding was provided by the University of Michigan 
Medical School, Department of Pathology, through the Anatomic 
Pathology Project Funding Committee.
Dr Lieberman is a clinical assistant professor at the Univer-
sity of Michigan Health System. His research interests include 
ultrastructural studies of placental chronic villitis and the use of 
high-resolution digital colposcopy in the evaluation of women 
with abnormal PAP smears.
References
    1.    Centers for Disease Control and Prevention. Novel inﬂ  uenza A 
(H1N1) virus infections in three pregnant women—United States, 
April–May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:497–
500. Erratum in MMWR Morb Mortal Wkly Rep. 2009;58:541. 
  2.   Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan 
WM, et al. Pandemic 2009 inﬂ  uenza A(H1N1) virus illness among 
pregnant women in the United States. JAMA. 2010; 303:1517–25.   
  3.   Goldenberg RL, Culhane JF, Johnson DC. Maternal infection and 
adverse fetal and neonatal outcomes. Clin Perinatol. 2005;32:523–
59. DOI: 10.1016/j.clp.2005.04.006
  4.   Redline RW. Placental pathology: a systematic approach with clini-
cal correlations. Placenta. 2008;29(Suppl A):S86–91.  
  5.   Harris  JW.  Inﬂ   uenza occurring in pregnant women: a statistical 
study of 1350 cases. J Am Med Assoc. 1919;72:970–2. 
  6.   Hardy JM, Azarowicz EN, Mannini A, Donald N, Medearis J. The 
effect of Asian inﬂ  uenza on the outcome of pregnancy, Baltimore, 
1957–1958. Am J Public Health Nations Health. 1961;51:1182–8. 
DOI: 10.2105/AJPH.51.8.1182
  7.   Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simp-
son CN. Possible association of inﬂ  uenza A with fetal loss: investi-
gation of a cluster of spontaneous abortions and stillbirths. Commun 
Dis Rep CDR Rev. 1994;4:R28–32.
  8.   Yawn DH, Pyeatte JC, Joseph JM, Eichler SL, Garcia-Bunuel R. 
Transplacental transfer of inﬂ  uenza virus. JAMA. 1971;216:1022–3. 
DOI: 10.1001/jama.216.6.1022
    9.   Mel’nikova VF, Tsinzerling VA, Aksenov OA, Tsinzerling AV. 
Chronic course of inﬂ  uenza with extrapulmonary involvement [in 
Russian]. Arkh Patol. 1994;56:33–8.
10.   Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, et al. H5N1 infec-
tion of the respiratory tract and beyond: a molecular pathology study 
[comment]. Lancet. 2007;370:1137–45. DOI: 10.1016/S0140-6736-
(07)61515-3
11.   Acs N, Banhidy F, Puho E, Czeizel AE. Maternal inﬂ  uenza during 
pregnancy and risk of congenital abnormalities in offspring. Birth 
Defects Res Part A Clin Mol Teratol. 2005;73:989–96.  
12.   Selten JP, Frissen A, Lensvelt-Mulders G, Morgan VA, Selten J-P, 
Frissen A, et al. Schizophrenia and 1957 pandemic of inﬂ  uenza: me-
ta-analysis. Schizophr Bull. 2010;36:219–28. DOI: 10.1093/schbul/
sbp147
13.   Uchide N, Ohyama K, Bessho T, Toyoda H. Induction of pro-in-
ﬂ  ammatory cytokine gene expression and apoptosis in human cho-
rion cells of fetal membranes by inﬂ  uenza virus infection: possible 
implications for maintenance and interruption of pregnancy during 
infection. Med Sci Monit. 2005;11:RA7–16.
14.   Goddijn M, Leschot NJ. Genetic aspects of miscarriage. Bail-
lieres Best Pract Res Clin Obstet Gynaecol. 2000;14:855–65. DOI: 
10.1053/beog.2000.0124
15.   Redline RW, Zaragoza M, Hassold T. Prevalence of developmental 
and inﬂ  ammatory lesions in nonmolar ﬁ  rst-trimester spontaneous 
abortions. Hum Pathol. 1999;30:93–100. DOI: 10.1016/S0046-
8177(99)90307-6
Address for correspondence: Richard W. Lieberman, Department of 
Pathology 4215, University of Michigan Medical School, 1301 Catherine 
Rd, Med Sci I, Ann Arbor, MI 48901, USA; email: jakrwl@umich.edu
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011  109 